![](https://aiolux-shared.s3.us-east-2.amazonaws.com/aiolux-logo-mid.png)
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[ADAP] Adaptimmune Therapeutics plc - Operating Cash Flow / Sales
Data updated 2024-Mar-23 (Saturday)Note: Detailed Statistics for Operating Cash Flow / Sales in Cashflow Statement for Adaptimmune Therapeutics plc [NASDAQ:ADAP] with frequency distribution chart that analyze trends & history . Operating Cash Flow / Sales or Revenue metric is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Operating Cash Flow / Sales values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Operating Cash Flow / Sales | -60,987.5% | -621.2% | -853.7% | -78.3% | 5.9% | -680.3% |
Sequential Quarter Growth | -9,717.4% | +27.2% | -990.0% | -1,438.8% | +100.9% | +8.9% |
Quarter-on Quarter Growth | -1,042,620.5% | +8.7% | -14.4% | +94.9% | -99.9% | +82.1% |
Annual Operating Cash Flow / Sales values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
Operating Cash Flow / Sales | -233.7% | -522.2% | 174.5% | -1,354.0% | -10,027.8% | -175.4% |
Year-on-Year Growth | +55.2% | -399.3% | +112.9% | +86.5% | -5,616.1% | -22.2% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly Operating Cash Flow / Sales values from 2015-Sep-30 grouped into buckets. Latest Operating Cash Flow / Sales value is -61 Thousand as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Adaptimmune Therapeutics plc mapped with quarterly Operating Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Operating Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Adaptimmune Therapeutics plc with subsequent post-earnings performance given Operating Cash Flow / Sales values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Operating Cash Flow / Sales - Low | 65% | 35% |
Operating Cash Flow / Sales - Medium | 28% | 72% |
Operating Cash Flow / Sales - High | 61% | 39% |
Operating Cash Flow / Sales (Sequential growth %) - Low | 41% | 59% |
Operating Cash Flow / Sales (Sequential growth %) - Medium | 31% | 69% |
Operating Cash Flow / Sales (Sequential growth %) - High | 81% | 19% |
Operating Cash Flow / Sales (QoQ growth %) - Low | 41% | 59% |
Operating Cash Flow / Sales (QoQ growth %) - Medium | 57% | 43% |
Operating Cash Flow / Sales (QoQ growth %) - High | 57% | 43% |
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2024-Jun-27 on Google
SEC Reports : Quarterly reports around 2024-Jun-27 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc